These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37756184)

  • 1. Paired Liver:Plasma PFAS Concentration Ratios from Adolescents in the Teen-LABS Study and Derivation of Empirical and Mass Balance Models to Predict and Explain Liver PFAS Accumulation.
    Baumert BO; Fischer FC; Nielsen F; Grandjean P; Bartell S; Stratakis N; Walker DI; Valvi D; Kohli R; Inge T; Ryder J; Jenkins T; Sisley S; Xanthakos S; Rock S; La Merrill MA; Conti D; McConnell R; Chatzi L
    Environ Sci Technol; 2023 Oct; 57(40):14817-14826. PubMed ID: 37756184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma concentrations of per- and Polyfluoroalkyl substances after bariatric surgery in adolescents from the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study.
    Baumert BO; Eckel SP; Goodrich JA; Li Z; Stratakis N; Walker DI; Zhao Y; Fischer FC; Bartell S; Valvi D; Lin X; Fuentes ZC; Inge T; Ryder J; Jenkins T; Kohli R; Sisley S; Xanthakos S; Rock S; La Merrill MA; McConnell R; Conti DV; Chatzi L
    Sci Total Environ; 2024 Jun; 930():172840. PubMed ID: 38685432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per- and polyfluoroalkyl substances in umbilical cord serum and body mass index trajectories from birth to age 10 years: Findings from a longitudinal birth cohort (SMBCS).
    Dai Y; Zhang J; Wang Z; Ding J; Xu S; Zhang B; Guo J; Qi X; Chang X; Wu C; Zhou Z
    Environ Int; 2023 Oct; 180():108238. PubMed ID: 37783122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring.
    Bil W; Zeilmaker MJ; Bokkers BGH
    Environ Health Perspect; 2022 Jul; 130(7):77005. PubMed ID: 35881550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to per- and polyfluoroalkyl substances and alterations in plasma microRNA profiles in children.
    Li Y; Baumert BO; Stratakis N; Goodrich JA; Wu H; Liu SH; Wang H; Beglarian E; Bartell SM; Eckel SP; Walker D; Valvi D; La Merrill MA; Inge TH; Jenkins T; Ryder JR; Sisley S; Kohli R; Xanthakos SA; Vafeiadi M; Margetaki A; Roumeliotaki T; Aung M; McConnell R; Baccarelli A; Conti D; Chatzi L
    Environ Res; 2024 Oct; 259():119496. PubMed ID: 38936497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bioavailability and protein binding of four anionic perfluoroalkyl substances in cell-based bioassays for quantitative in vitro to in vivo extrapolations.
    Qin W; Henneberger L; Huchthausen J; König M; Escher BI
    Environ Int; 2023 Mar; 173():107857. PubMed ID: 36881956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II).
    Petriello MC; Mottaleb MA; Serio TC; Balyan B; Cave MC; Pavuk M; Birnbaum LS; Morris AJ
    Environ Int; 2022 Jan; 158():106907. PubMed ID: 34763231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal relative potency factors based on immunotoxicity for the risk assessment of mixtures of per- and polyfluoroalkyl substances (PFAS) in human biomonitoring.
    Bil W; Ehrlich V; Chen G; Vandebriel R; Zeilmaker M; Luijten M; Uhl M; Marx-Stoelting P; Halldorsson TI; Bokkers B
    Environ Int; 2023 Jan; 171():107727. PubMed ID: 36628859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of cord plasma per- and polyfluoroakyl substances (PFAS) with neonatal and child body composition and adiposity: The GUSTO study.
    Chen LW; Ng S; Tint MT; Michael N; Sadananthan SA; Ong YY; Yuan WL; Chen ZY; Chen CY; Godfrey KM; Tan KH; Gluckman PD; Chong YS; Eriksson JG; Yap F; Lee YS; Fortier MV; Velan SS; Chan SY
    Environ Int; 2024 Jan; 183():108340. PubMed ID: 38043321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.
    Nyström J; Benskin JP; Plassmann M; Sandblom O; Glynn A; Lampa E; Gyllenhammar I; Moraeus L; Lignell S
    Environ Res; 2022 May; 208():112674. PubMed ID: 34998808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Route-Specific Pharmacokinetics of PFAS in Mice by Coupling
    Zhu Y; Pan X; Jia Y; Yang X; Song X; Ding J; Zhong W; Feng J; Zhu L
    Environ Health Perspect; 2023 Dec; 131(12):127012. PubMed ID: 38088889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between maternal exposure to per- and polyfluoroalkyl substances and serum markers of liver function during pregnancy in China: A mixture-based approach.
    Liao Q; Tang P; Fan H; Song Y; Liang J; Huang H; Pan D; Mo M; LeiLei ; Lin M; Chen J; Wei H; Long J; Shao Y; Zeng X; Liu S; Huang D; Qiu X
    Environ Pollut; 2023 Apr; 323():121348. PubMed ID: 36842621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between serum per- and polyfluoroalkyl substances as mixtures and lipid levels: A cross-sectional study in Jinan.
    Liu Y; Zhang H; Xu F; Zhang X; Zhao N; Ding L
    Sci Total Environ; 2024 May; 923():171305. PubMed ID: 38423340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying levels of per- and polyfluoroalkyl Substances (PFAS) in water and serum after contamination from agricultural biosolid application.
    Criswell RL; Simones T; Chatterjee M; Waite J; Diaz S; Smith A
    Environ Int; 2024 Aug; 190():108850. PubMed ID: 38941944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of children and adolescents from Northeastern Slovenia to per- and polyfluoroalkyl substances.
    Runkel AA; Stajnko A; Snoj Tratnik J; Mazej D; Horvat M; Přibylová P; Kosjek T
    Chemosphere; 2023 Apr; 321():138096. PubMed ID: 36773682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.
    Dunder L; Lind PM; Salihovic S; Stubleski J; Kärrman A; Lind L
    Environ Res; 2022 Aug; 211():112903. PubMed ID: 35231461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
    Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
    Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Male Reproductive Function in Young Adulthood: Combined Exposure to Seven PFAS.
    Hærvig KK; Petersen KU; Hougaard KS; Lindh C; Ramlau-Hansen CH; Toft G; Giwercman A; Høyer BB; Flachs EM; Bonde JP; Tøttenborg SS
    Environ Health Perspect; 2022 Oct; 130(10):107001. PubMed ID: 36197086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Signatures of Youth Exposure to Mixtures of Per- and Polyfluoroalkyl Substances: A Multi-Cohort Study.
    Goodrich JA; Walker DI; He J; Lin X; Baumert BO; Hu X; Alderete TL; Chen Z; Valvi D; Fuentes ZC; Rock S; Wang H; Berhane K; Gilliland FD; Goran MI; Jones DP; Conti DV; Chatzi L
    Environ Health Perspect; 2023 Feb; 131(2):27005. PubMed ID: 36821578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.